Cristina Silva

Cristina Silva



Region Covered



Cristina Tercio da Silva and Alexandre Ramos are consultants for PPi Healthcare Consulting.

They are the PPi HC representatives for the Portuguese market.

They bring more than  30 years of combined experience with market access, pricing & reimbursement engagements, applications and negotiations for innovative products, orphans and non-orphans, with a strong and deep experience acquired on Agency demands.

Cristina is a Pharmacist from FFUL Lisbon, working for more than 10 years in market access for the Portuguese market.

Alexandre is a Pharmacist from FFUL Lisbon and a NOVA MBA, working in market access for more than 20 years.



With their depth of market access experience across the EU, Adam Barak and his team at PPi Healthcare are well-positioned to provide timely, insightful guidance on pricing and reimbursement. ProMetic’s global strategic launch plans involving ultra-orphan therapies, have been greatly enhanced by our collaboration with PPi.

Kristine Dorward, Director, Marketing & Business Development, ProMetic Life Sciences Inc.

I want to let you know that the feedback from my colleagues after your presentation was that they are impressed by the amount of information that you have gathered within the research within such a short period.

Ramona Schmid, Global Market Access, Pricing and Reimbursement Manager, HRA Pharma

I have worked with PPi on several projects and I will work with them again. The first project was a European pricing study for an orphan product. Having already completed one study with a competitor, I found the PPi team to be particularly insightful, having taken the time to completely understand this complex project. Recently I completed an assessment to inform the collection of pharmacoeconomic data in a clinical study in the US and Europe. The team again were very insightful and we had unexpected value-added when we found a member of the PPi had been involved in the pricing and reimbursement activities relating to one of our comparables. Great team, great results!

Thomas W. MacAllister JD, PhD,Vice President of R&D and General Counsel, Remedy Pharmaceuticals